Nippon Sanso Holdings Corporation (TYO:4091)
Japan flag Japan · Delayed Price · Currency is JPY
5,445.00
+71.00 (1.32%)
Aug 1, 2025, 3:30 PM JST

Ligand Pharmaceuticals Revenue

Nippon Sanso Holdings had revenue of 314.76B JPY in the quarter ending June 30, 2025, a decrease of -4.41%. This brings the company's revenue in the last twelve months to 1.29T, up 1.42% year-over-year. In the fiscal year ending March 31, 2025, Nippon Sanso Holdings had annual revenue of 1.31T with 4.22% growth.

Revenue (ttm)
1,293.51B
Revenue Growth
+1.42%
P/S Ratio
1.82
Revenue / Employee
65.48M
Employees
19,754
Market Cap
2,356.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251,308.02B52.94B4.22%
Mar 31, 20241,255.08B68.40B5.76%
Mar 31, 20231,186.68B229.51B23.98%
Mar 31, 2022957.17B138.93B16.98%
Mar 31, 2021818.24B-32.00B-3.76%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shin-Etsu Chemical2,591.87B
Nippon Steel8,512.77B
Nippon Paint Holdings1,660.13B
Nitto Denko1,010.76B
Asahi Kasei3,039.70B
JFE Holdings4,859.65B
Mitsubishi Chemical Group4,271.06B
AGC Inc.2,047.88B
Revenue Rankings